StockData
Rein Therapeutics, Inc. logo

Rein Therapeutics, Inc. (RNTX) stock

RNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.36−0.00 (-0.31%)

Close on Nov 18, 2026Market cap $30.65MP/E –Yield 0.00%

Rein Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Rein Therapeutics's market cap was $51.97M on Nov 11, 2026, against $39.47M a year earlier. Over the last 5 years it ranged from $5.31M to $89.10M, with a median of $32.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$51.97M+78.2%
2025Dec 31, 2025$29.16M-41.5%
2024Dec 31, 2024$49.83M+259.9%
2023Dec 29, 2023$13.84M+28.6%
2022Dec 30, 2022$10.76M-78.9%
2021Dec 31, 2021$50.98M+22.9%
2020Dec 31, 2020$41.47M+160.2%
2019Dec 31, 2019$15.94M+28.7%
2018Dec 31, 2018$12.38M-92.0%
2017Dec 29, 2017$155.14M–

More Rein Therapeutics figures

See a number that looks wrong?